Semisolid dosage forms are neither solid nor liquid, however, they are a combination or mixture of both, and they used for both local and systemic effects. Pharmaceutical semisolid dosage forms such as creams, ointments, gels, suppositories, and paste are used for topical application. Semisolid dosage forms are intended used as drug carriers that are transported topically through the skin, buckle tissue, rectal tissue, outer ear lining nasal mucosa, urethral membrane, vagina, and cornea. The semisolid may adhere adequately before washing on the surface of the application; this helps to extend the supply of drugs on the application site.
Liquid dosage forms are effective pharmaceutical products containing a mixture of active pharmaceutical ingredients (API/Drug) and non drug components (excipients). It is a dose of a drug used as a medicine for consumption or administration. Many liquid dosage forms are used in the pharmacy, but the most commonly used are syrup, suspension, and elixirs. The general category of liquid oral doses includes a broad range of dosage forms, broadly classified as monophasic and biphasic. Whereas dosage forms in both types comprise at least one drug, monophasic forms are homogeneous and completely dissolve in liquid, whereas biphasic forms in a vehicle do not dissolve.
The difference between a Gel and Cream:
A gel is transparent, and a cream is not. Gels are mostly colourless and disappear when applied. Despite having a colour base, creams are also not visible once applied, although gels are absorbed faster.
a suspension is a heterogeneous mixture containing solid particles that are sufficiently large for sedimentation. Usually they must be larger than one micrometer. A suspension is a heterogeneous mixture in which the solute particles do not dissolve but get suspended throughout the bulk of the medium.
Semisolid dosage forms are neither solid nor liquid, however, they are a combination or mixture of both, and they used for both local and systemic effects. Pharmaceutical semisolid dosage forms such as creams, ointments, gels, suppositories, and paste are used for topical application. Semisolid dosage forms are intended used as drug carriers that are transported topically through the skin, buckle tissue, rectal tissue, outer ear lining nasal mucosa, urethral membrane, vagina, and cornea. The semisolid may adhere adequately before washing on the surface of the application; this helps to extend the supply of drugs on the application site.
Liquid dosage forms are effective pharmaceutical products containing a mixture of active pharmaceutical ingredients (API/Drug) and non drug components (excipients). It is a dose of a drug used as a medicine for consumption or administration. Many liquid dosage forms are used in the pharmacy, but the most commonly used are syrup, suspension, and elixirs. The general category of liquid oral doses includes a broad range of dosage forms, broadly classified as monophasic and biphasic. Whereas dosage forms in both types comprise at least one drug, monophasic forms are homogeneous and completely dissolve in liquid, whereas biphasic forms in a vehicle do not dissolve.
The difference between a Gel and Cream:
A gel is transparent, and a cream is not. Gels are mostly colourless and disappear when applied. Despite having a colour base, creams are also not visible once applied, although gels are absorbed faster.
a suspension is a heterogeneous mixture containing solid particles that are sufficiently large for sedimentation. Usually they must be larger than one micrometer. A suspension is a heterogeneous mixture in which the solute particles do not dissolve but get suspended throughout the bulk of the medium.
Discussion on the 2 kinds of Disperse Systems 1. Suspensions 2. Emulsions. The principles of emulsification, types and examples of emulsifying agents used.
D-pharma B- Pharma topical preparation pharmaceutics pharmaceutical chemistry Pharmacy topical preparations ointment page gel cream limit suppositories access accessories pessesries paste lotion liniment topical preparations are those drugs that are applied locally to on the mucus membrane administered by rubbing or we are spreading over them on the skin to protect and moisturizer and various therapeutic effect they contain silver nitrate kilora accident gluconate ionic silver boric acid bleaching powder potassium permanganate hydrogen peroxide sodium chloride jink jink oxide ointment base vehicles
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
3. INTRODUCTION
Pharmaceutical semisolid preparations include ointments, pastes, cream emulsions,
and gels. Their common property is the ability to cling to the surface of application
for reasonable duration before they are washed or worn off. This adhesion is due to
their plastic rheological behaviour, which allows the semisolids to retain their shape
and cling as a film until acted upon by an outside force.
Ointments are semisolid preparations intended for external application to the skin
or mucous membranes. Ointments may be medicated or not. Unmedicated
ointments are used for the physical effects they provide as protectants, emollients,
or lubricants.
Ointments are fatty preparations that are usually self-occlusive and are generally
used on dry lesions. Unmedicated ointments are used as emollients to soothe,
smooth and hydrate dry skin conditions
Ointments, in general, are composed of fluid hydrocarbons meshed in a matrix of
higher-melting solid hydrocarbons.
An ointment is classified as any semi-solid containing fatty material and intended
for external application (U.S. Pharmacopeia).
In 19th century, ointments were based on lard, a compounding material, the
usefulness of which was severely limited by its tendency to turn rancid.
3
4. ADVANTAGES
Handling of ointments is easier than bulky liquid dosage forms.
They are chemically more stable than liquid dosage forms.
They facilitate application of the directly to the effected body part and
avoid exposure of other parts to the drug.
They are suitable for patients who find it difficult to take the drugs by
parenteral and oral routes.
They prolong the contact time between the drug and effected area.
The bioavailability of drugs administered as ointments is more since it
prevents passage through liver.
4
5. DISADVANTAGES
They are bulkier than solid dosage forms.
When applications of an exact quantity of ointment to the affected area is
required, it is difficult to ascertain the same.
They are less stable than solid dosage forms.
5
6. OINTMENT BASES (VEHICLE)
The vehicles used for a pharmaceutical semisolid are called as bases and
they differ from that used for cosmetics because for a cosmetic,
penetration into skin is not desired. Penetration or protection is desired in
a pharmaceutical semisolid, and its cosmetic effect or appearance on the
skin is less important. The solubility and stability of the drug in the base,
as well as the nature of the skin lesion, determine the choice of the
semisolid vehicle.
6
7. Contd.
The USP recognizes four classes of semisolid bases under the general
classification of ointment:
OINTMENT BASES
7
WATER
REMOVABLE
BASES
WATER
SOLUBLE
BASES
ABSORPTION
BASES
OLEAGINOUS
BASES
8. OLEAGINOUS BASES
These bases are usually anhydrous and consist of substances such
hydrocarbons, vegetable oils, silicones and certain synthetic esters, either
alone or in combination. These bases are characterised by (i) low capacity
to absorb water (emollient effect), (ii) exert high occlusiveness by forming
water impermeable layer of skin, (iii) greasy and thus difficult to remove
from skin, (iv) prolonged contact with skin and (v) poor aesthetic appeal.
8
9. Contd.
Hydrocarbons Bases: These bases include hard, liquid, and soft paraffins
1. Soft paraffin (petrolatum): The most common base used in ointment
because of its consistency, its bland and neutral characteristics, and its
ability to spread easily on the skin.
2. Liquid paraffin (mineral oil): It is obtained from petroleum, as is
petrolatum, by collection of a particular viscosity-controlled fraction. Soft
petrolatum is a mixture of 90% white petrolatum with 10% mineral oil.
3. Hard paraffin (hydrocarbon waxes): These waxes are used to increase
viscosity of the mineral oil in creams and ointments, as it prevents the
separation.
Vegetable oils: such as peanut oil, almond oil, sesame oil and olive oil are
mono-, di-, and tri glycerides mixtures of unsaturated and saturated fatty
acids.
9
10. ABSORPTION BASES
These bases are usually anhydrous and they do absorb aqueous solutions
and can be considered water-in-oil emulsions. These bases do not
absorb water on contact, but with sufficient agitation.
Absorption bases are of two types:
(a) Anhydrous absorption bases: those that permit the incorporation of
aqueous solutions resulting in the formation of water-in-oil (W/O)
emulsions (e.g., hydrophilic petrolatum). Anhydrous lanolin is capable of
absorbing about 30-50% of its weight of water to form an emulsion.
(b) Hydrous absorption bases: those that are W/O emulsions(syn:
emulsion bases) that permit the incorporation of additional quantities of
aqueous solutions (e.g., lanolin).These bases may be used as emollients,
although they do not provide the degree of occlusion afforded by the
oleaginous bases.
10
11. WATER REMOVABLE BASES
Water-removable bases are oil-in-water emulsions commonly called
creams. Because the external phase of the emulsion is aqueous, they are
easily washed from skin and are often called water-washable bases. They
may be diluted with water or aqueous solutions. Hydrophilic Ointment,
USP, is an example of this type of base.
11
12. WATER SOLUBLE BASES
Water-soluble bases do not contain oleaginous components. They are
completely water washable and often referred to as greaseless. Because
they soften greatly with the addition of water, large amounts of aqueous
solutions are not effectively incorporated into these bases. They mostly
are used for incorporation of solid substances. Polyethylene glycol (PEG)
ointment, NF, is the prototype example of a water-soluble base.
Polyethylene Glycol Ointment, NF, PEG is a polymer of ethylene oxide and
water represented by the formula H(OCH2CH2)nOH, in which n
represents the average number of oxyethylene groups.
12
13. Oleaginous Ointment Bases Absorption Ointment Bases Water/Oil Emulsion Ointment
Bases
Oil/Water Emulsion Ointment
Bases
Water-miscible Ointment
Bases
Composition oleaginous compounds oleaginous base + w/o
surfactant
oleaginous base + water (<
45% w/w) + w/o surfactant
(HLB <8)
oleaginous base + water (>
45% w/w) + o/w surfactant
(HLB >9)
Polyethylene Glycols
(PEGs)
Water Content anhydrous anhydrous hydrous hydrous anhydrous, hydrous
Affinity for Water hydrophobic hydrophilic hydrophilic hydrophilic hydrophilic
Spreadability difficult difficult moderate to easy easy moderate to easy
Washability Non-washable Non-washable non- or poorly washable washable washable
Stability oils poor; hydrocarbons
better
oils poor; hydrocarbons better unstable, especially alkali soaps
and natural colloids
unstable, especially alkali
soaps and natural colloids;
non-ionic better
stable
Drug Incorporation
Potential
solids or oils (oil soluble only) solids, oils, and aqueous
solutions (small amounts)
solids, oils, and aqueous
solutions (small amounts)
solid and aqueous solutions
(small amounts)
solid and aqueous
solutions
Drug Release Potential* poor poor, but > oleaginous fair to good fair to good good
Occlusiveness yes yes sometimes no no
Uses protectants, emollients (+/-
), vehicles for hydrolysable
drugs
protectants, emollients (+/-),
vehicles for aqueous solutions,
solids, and non-hydrolysable
drugs
emollients, cleansing creams,
vehicles for solid, liquid, or
non-hydrolysable drugs
emollients, vehicles for solid,
liquid, or non-hydrolysable
drugs
drug vehicles
Examples White Petrolatum, White
Ointment
Hydrophilic Petrolatum,
Anhydrous Lanolin,
Aquabase™, Aquaphor®
Cold Cream type, Hydrous
Lanolin, Rose Water Ointment,
Hydrocream™
Hydrophilic Ointment,
Dermabase™, Velvachol®,
Unibase®
PEG Ointment, Polybase™
13
14. Selection of the Appropriate Bases
Selection of the base to use in the formulation of an ointment depends
on careful assessment of a number of factors, including the following:
Desired release rate of the drug substance from the ointment base
Desirability of topical or percutaneous drug absorption
Desirability of occlusion of moisture from the skin
Stability of the drug in the ointment base
Effect, if any, of the drug on the consistency or other features of the
ointment base
Desire for a base easily removed by washing with water
Characteristics of the surface to which it is applied
14
15. Various Methods of Ointment’s
Preparation
Ointments are prepared by two general methods, depending primarily on
the nature of the ingredients.
METHODS
1. Incorporation Method
2. Fusion Method
15
16. INCORPORATION METHOD
The components are mixed until a uniform preparation is attained. On a
small scale, as in extemporaneous compounding, the pharmacist may mix
the components using a mortar and pestle, or a spatula may be used to
rub the ingredients together on an ointment slab (a large glass or
porcelain plate or pill tile). Others will use an ointment mill, an electronic
mortar and pestle, or a device called an “Unguator,” (Fig. 1) which allows
a pharmacist to place the ingredients in a plastic ointment jar with a
special lid that allows for a mixing blade to be used to mix the ingredients
in the dispensing container.
16
17. Contd.
Ointment or roller mills can be used to force coarsely formed ointments
through stainless steel or ceramic rollers to produce ointments uniform in
composition and smooth in texture (Fig. 2). Small ointment mills also find
use in product development laboratories and in small-batch manufacture
or compounding.
Fig 1. Unguator Electronic mortar and pestle. Fig. 2 Ointment roller mill
17
18. Fusion Method
By the fusion method, all or some of the components of an ointment are
combined by being melted together and cooled with constant stirring
until congealed. Components not melted are added to the congealing
mixture as it is being cooled and stirred. Naturally, heat-labial substances
and any volatile components are added last, when the temperature of the
mixture is low enough not to cause decomposition or volatilization of the
components. Substances may be added to the congealing mixture as a
solution or as insoluble powders levigated with a portion of the base. on
a small scale, fusion may be conducted in a large scale, it is carried out in
large steam jacketed kettles. Once congealed, the ointment may be
passed through an ointment mill (in large-scale manufacture) or rubbed
with a spatula or in a mortar to ensure a uniform texture.
18
19. ROUTES OF PENETRATION
When a drug system is applied topically, the drug diffuses out its vehicle
onto the surface tissues of the skin. There are three potential portals of
entry: through the follicular region (transfollicular), through the sweat
ducts, or through the unbroken stratum corneum between the
appendages(transrpidermal). There is little convincing evidence that
eccrine sweat glands play any significant role in cutaneous permeability.
Material may enter the ducts, and to be no penetration from these areas
to the dermis.
19
21. Contd.
Once a substance passes through the stratum corneum, there is
apparently no significant further hindrance to penetration of the
remaining epidermal layers and corium, there is then a ready entry into
the circulation via the capillaries. The concentration gradient essentially
ends in the dermal layer at the beginning of the circulation. The systemic
circulation acts as a reservoir or “sink” for the drug.
Diffusion through the horny layer is a passive process. There is little
evidence to support specialized active transport systems for cells of the
stratum corneum. The passive process is affected only by the substance
being absorbed, by the medium in which the substance is dispersed, and
by ambient conditions.
21
22. EVALUATION OF OINTMENT
There are some tests for evaluation of the ointment formulation and
some are as follow:
1. Rate of absorption
2. Non-irritancy
3. Rate of penetration
4. Rate of drug release
5. Rheological properties
6. Content uniformity
22
23. Test for rate of absorption
The diadermatic ointment should be evaluated for the rate of absorption
of drug into the blood stream. This test can be done in-vivo only.
The ointment should be applied over a definite area of the skin by
rubbing.
At regular intervals of time, serum and urine samples should be analysed
for the quantity of drug absorbed.
The rate of absorption i.e., the amount of drug absorbed per unit time
should be more.
23
24. Test for non-irritancy
The bases used in the formulation of ointments may cause irritation or
allergic reactions.
Non-irritancy of the preparation is evaluated by patch test.
In this test 24 human volunteers are selected.
Definite quantity of ointment is applied under occlusion daily on the back
or volar fore arm for 21 days.
Daily the type of pharmacological action observed isnoted.
No visible reaction or erythema or intense erythemawith edema and
vesicular erosion should occur.
A good ointment base shows no visible reaction.
24
25. Test for rate of penetration
The rate of penetration of a semisolid dosage form is crucial in the onset
and duration of action of the drug.
Weighed quantity of the preparation should be applied over selected
area of the skin for a definite period of time.
Then the preparation left over is collected and weighed.
The difference between the initial and the final weights of the preparation
gives the amount of preparation penetrated through the skin and this
when divided by the area and time period of application gives the rate of
penetration of the preparation.
The test should be repeated twice or thrice.
25
26. Test for rate of drug release:
To assess the rate of release of medicament, small amount of the
can be placed on the surface of nutrient agar contained in a petri dish or
alternately in a small cup cut in the agar surface.
If the medicament is bactericidal the agar plate is previously seeded with
suitable organism like Staphylococcus aureus.
After a suitable period of incubation, the zone of inhibition is measured
and correlated with the rate of release.
Test for content uniformity:
The net weight of contents of ten filled ointment containers are
determined.
The results should match each other and with the labelled quantity.
26
27. Reference
Lachman/ Lieberman’s, The Theory and Practice of Industrial Pharmacy,
Fourth Edition, by CBS Publishers.
Aulton’s Pharmaceutics, The Design and Manufacture of Medicines,
Fourth Edition, by Elsevier Ltd.
Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems,
Tenth Edition, by Lippincott Williams & Wilkins, a Wolters Kluwer business.
27